MP23-06 A RANDOMIZED, CONTROLLED TRIAL OF ACTIVE VS. PASSIVE VOIDING TRIALS

You have accessJournal of UrologyInfections/Inflammation/Cystic Disease of the Genitourinary Tract: Kidney & Bladder II1 Apr 2017MP23-06 A RANDOMIZED, CONTROLLED TRIAL OF ACTIVE VS. PASSIVE VOIDING TRIALS James Mills, Nathan Shaw, Helen Hougen, Hannah Agard, Robert Case, Timothy McMurry, Noah Schenkman, and Tracey Krupski James MillsJames Mills More articles by this author , Nathan ShawNathan Shaw More articles by this author , Helen HougenHelen Hougen More articles by this author , Hannah AgardHannah Agard More articles by this author , Robert CaseRobert Case More articles by this author , Timothy McMurryTimothy McMurry More articles by this author , Noah SchenkmanNoah Schenkman More articles by this author , and Tracey KrupskiTracey Krupski More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2017.02.734AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES There are national quality initiatives to prevent catheter-associated urinary tract infections (CAUTI) due to morbidity and cost. Differences between active and passive voiding trials have not been previously studied in the general hospitalized population. Active voiding trials entail filling the bladder with saline before catheter removal. Passive voiding trials involve the bladder filling with urine naturally after catheter removal. We assessed the effects of active vs passive voiding trials on time to hospital discharge and the rates of urinary tract infection (UTI) and urinary retention (UR). METHODS In a single-center, single-blind, randomized, controlled trial, patients who had urethral catheter removal were randomized to a standardized active voiding trial or passive voiding trial. Patients undergoing urethral or bladder surgery were excluded. The outcomes of interest were the patient's time to hospital discharge after the catheter removal and the rates of UTI (defined by the National Surgical Quality Improvement Program criteria) and UR within 2 weeks of catheter removal. Logistic regression was used to identify risk factors for urinary retention. RESULTS We enrolled 274 patients. Table 1 shows the differences in outcomes between active and passive voiding trials. BPH (OR 5.3, p=0.007); neurological disease (OR 3.1, p=0.03); and admission to a neurosurgical ward (OR 3.6, p=0.009) were associated with increased urinary retention. CONCLUSIONS Patients in the active group had 64% fewer urinary tract infections than patients in the passive voiding trial group. Although patients in the active group voided nearly 3 hours sooner than patients in the passive group, there was no difference between the groups in time to hospital discharge. There was no difference in the rate of UR between the groups. BPH, neurological disease, and admission to a neurosurgical ward increased the odds of urinary retention. © 2017FiguresReferencesRelatedDetails Volume 197Issue 4SApril 2017Page: e295 Advertisement Copyright & Permissions© 2017MetricsAuthor Information James Mills More articles by this author Nathan Shaw More articles by this author Helen Hougen More articles by this author Hannah Agard More articles by this author Robert Case More articles by this author Timothy McMurry More articles by this author Noah Schenkman More articles by this author Tracey Krupski More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...